Public limited company · Ålesund
HOFSETH BIOCARE ASA
ActiveManufacture of oils and fats (10.410)
The life line 2009–2026
Operating revenue per year, with recorded events above. As a table
Operating revenue 2025: NOK 259.9m.
- Fullmakt kapitalforhøyelse§ 14
- Kapital§ 14
- Chair took office§ 07
- Managing director took office§ 07
- Founded§ 16
Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.
In brief
HOFSETH BIOCARE ASA is a public limited company in Ålesund, founded in 2009, in the industry manufacture of oils and fats. The chief executive is Jon Olav Ødegård, and the chair of the board is Linda Christin Hoff. In 2025 the company had NOK 259.9m in operating revenue and a net profit of NOK −127.6m; the group had revenue of NOK 256.3m. The largest owner is SIX SIS AG with 21.0%.
Put together by Intelligo from the sections below; each figure stands with its source where it belongs.
Overview
§ 01 Latest changes
4 changes, latest 13 Nov 2026
- Number of employees 85 → 83
- Number of employees 83 → 85
- Endring av styre
- Changed capital 489415639 → 522235638
Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →
Overview
§ 02 Worth knowing
2 points
- NoteOperating loss three years running, 2023–2025
- NoteNegative equity in 2025
Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate
Overview
§ 03 Key figures
Revenue NOK 259.9m in 2025
Revenue
NOK 259.9m
−2.7% from 2024
20232025
Operating profit
NOK −102.7m
−16.1% from 2024
20232025
Net profit
NOK −127.6m
−30.3% from 2024
20232025
Equity
NOK −6.3m
−105.2% from 2024
20232025
Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →
Finances
§ 04 Where the money comes from and goes
Financial year 2025
Of every krone of operating revenue in 2025:
- Wages and social costs 27%
- Depreciation 14%
- Other operating costs 36%
- Not specified in the source 63%
Costs exceeded revenue: the operating result was NOK −102.7m.
Source: the Register of Company Accounts via areg.no, read 15 Nov 2026
Finances
§ 05 Financial health
Equity ratio 0.0%
- HOFSETH BIOCARE ASA, 2025
- Industry median, assumed: NOK 49.4m · 3.5% · 55.2% · +2.4%
Equity NOK −6.3m0% of the assets (NOK 443.3m)
Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 25 companies in 10.410 Manufacture of oils and fats, not stated by the source.
Finances
§ 06 Accounts
17 years, latest 2025
| NOK 1,000 | 2023–25 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating revenue | 259,857 | 267,026 | 218,418 | |
| Operating profit | −102,668 | −88,427 | −86,445 | |
| Profit before tax | −127,580 | −97,898 | −92,996 | |
| Net profit | −127,580 | −97,898 | −92,996 | |
| Total assets | 443,274 | 377,251 | 396,716 | |
| Equity | −6,321 | 120,422 | 74,612 | |
| Liabilities | 449,597 | 256,829 | 322,104 |
Source: the Register of Company Accounts, read 15 Nov 2026 · All 17 years →
Management and ownership
§ 07 Officers
9 officers now
- Jon Olav ØdegårdChief executive since 2013
- ECIT NORIAN ASAccountant
- ERNST & YOUNG ASAuditor since 2014
- Linda Christin HoffChair of the board since 2024
- Crawford Linden Alexander CurrieBoard member since 2022
- Eva Maria BechBoard member since 2024
Source: the Brønnøysund Register Centre, read 30 Aug 2026 · All 9 roles, former ones too →
Management and ownership
§ 08 Signature, procuration and authorisations
3 valid powers of attorney
The board has 3 authorisations in force now: acquisition of own shares, until 30 Jun 2027; acquisition of own shares, until 30 Jun 2027; capital increase, until 30 Jun 2027.
Source: authorisations from the announcements of the Register of Business Enterprises, read 2 Nov 2026
Management and ownership
§ 09 Owners
161 shareholders · largest 21.0%
| Owner | Share |
|---|---|
| SIX SIS AG | 21.0% |
| RH INDUSTRI AS | 16.9% |
| HOFSETH INTERNATIONAL AS | 14.5% |
| 158 others | 47.6% |
Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 161 owners →
Management and ownership
§ 10 Group
3 subsidiaries
The group 2025: operating revenue NOK 256.3m (−3.5%).
Share held. Source: the Tax Administration's shareholder register, fetched 31 Jul 2026 · The whole group →
Management and ownership
§ 11 Portfolio
Holds shares in 3 companies
Source: the Tax Administration's Register of Shareholders, read 31 Jul 2026 · The whole portfolio →
Management and ownership
§ 12 Network
18 connections
- Person
- Company
2 people link HOFSETH BIOCARE ASA to 13 other companies: Jon Olav Ødegård 6 and Linda Christin Hoff 7.
Source: the Brønnøysund Register Centre, read 30 Aug 2026 · Explore the network →
Events and registers
§ 13 Events
100 since 2015
Events per year
20152026
Since 2015: 153 announcements, 11 register changes and 1 new and 1 former owners. Most happened in 2020 and 2026.
Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 2 Nov 2026. Register changes are Intelligo's own observations. · All 100 events →
Events and registers
§ 14 Notices
153, latest 29 Aug 2026
- Styre
- Kapital
- Vedtektsdato
Source: The Brønnøysund Register Centre's announcements ↗, read 2 Nov 2026 · All 153 →
Events and registers
§ 15 Charges
Not fetched yet
Events and registers
§ 16 Other registers
Found in 3 of 7
- The Central Coordinating RegisterRegistered 29 Aug 2009
- VATRegistered
- The Register of Business EnterprisesRegistered 29 Aug 2009
- The Cleaning RegisterNot registered
- The Register of Staffing AgenciesNot registered
- Smiley scheme, the Norwegian Food Safety AuthorityNot registered
- The Financial Supervisory Authority's licence registerNot registered
Purpose: Utvikling, foredling, markedsføring og salg av marine ingredienser som marine oljer, kalslum- og proteinprodukter, samt samarbeid med og deltakelse og eierskap i virksomheter som driver relatert virksomhet.
Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026
Market
§ 17 Tenders
None registered
No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.
Market
§ 18 Vacancies
None registered
No vacancies.No open ads at NAV. Checked 15 Nov 2026.
Market
§ 19 Competitors
Industry code 10.410
The companies most like it:
Compare themThe selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →
Last
§ 20 Questions and answers
6 questions
- Who is the chief executive of HOFSETH BIOCARE ASA?
Jon Olav Ødegård, since 2013. § 07 - Who owns HOFSETH BIOCARE ASA?
161 shareholders. The largest is SIX SIS AG with 21.0%, RH INDUSTRI AS with 16.9% and HOFSETH INTERNATIONAL AS with 14.5%. § 09 - What was the revenue in 2025?
NOK 259.9m in the company and NOK 256.3m in the group. § 06 - Who is the auditor?
ERNST & YOUNG AS, from 27 Aug 2014. § 07 - Where is HOFSETH BIOCARE ASA based?
Keiser Wilhelms gate 24, 6003 Ålesund. - When was HOFSETH BIOCARE ASA founded?
5 Aug 2009, registered in the Register of Business Enterprises 29 Aug 2009. § 16
The answers come from the sections linked to, with their sources.